Skip to content
Screener

Omeros OMER Operating margin

Discontinued — last reported Q3 '21

Operating margin at other companies

Immunome logo
ImmunomeIMNM
-5,947.9%-12,002pp
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-242%—
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-476.2%-507pp
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-5,266.4%-9,520pp
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
-4,558.4%-9,354pp
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-39,428.9%-49,795pp

Other financials

Income statement

See full
Revenue$9.9M—
Gross profit$29.7M—
Operating income-$40.9M-9.2%
Net income$56.1M+268%
EPS (diluted)-$0.59-20.4%

Balance sheet

See full
Cash & equivalents$1.9M-55.3%
Total debt$13.5M-30.3%
Total equity-$63.3M+70.3%
Total assets$286.2M+21.7%

Cash flow

See full
Operating cash flow-$14.5M+59.5%
CapEx--100%
Free cash flow-$14.5M+59.6%

Valuation

See full
Market cap$958.97M+245%
P/S10.7×—

Profitability

See full
Gross margin98.9%—
Net margin-136.6%—
FCF margin-121.6%—

Returns & leverage

See full
Return on equity86.6%—
Debt / equity0.3×-1.1×
Current ratio3×+1.9×

Where this comes from

Calculated from Omeros’s reported figures.

operating income/total revenue=-181.8%

Based on trailing twelve months.

The source filing: Omeros’s 10-Q, filed November 9, 2021. Open the filing →

Filed
Nov 9, 2021, 4:10 PM EST
Fiscal quarter
Q3 FY2021
Calendar quarter
Q3 2021
Accession
0001558370-21-015289

FAQ

What is Omeros's operating margin?
Omeros (OMER) reported operating margin of -181.8% in Q3 2021.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Ask your AI about Omeros's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude